Close

Analyst Ratings for Sigilon Therapeutics (SGTX)

SGTX Rating Summary

SGTX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on SGTX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $4.50 (+592.3%) * Over Last 12-Mos
Rating Score: 6 / 10   Percentile Rank: 63%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/18/2023 Canaccord Genuity Whitney Ijem New Coverage Buy
(N/A)		 N/A
(N/A)		 0.41
(0.65)		 58.54% Details
11/30/2021 Jefferies Dennis Ding Downgrade Hold
(Buy)		 4.00
(N/A)		 3.77
(0.65)		 -82.76% Details
Like SGTX Ratings? Also take a look at MRNA, RUBY, MCRB, AXLA

SGTX Ratings News